136 related articles for article (PubMed ID: 4453533)
1. [Leukomycin in the treatment of various otorrhinelaringological diseases].
Astorga Díaz R
Prensa Med Mex; 1974; 39(7-8):354-7. PubMed ID: 4453533
[No Abstract] [Full Text] [Related]
2. Clinical appraisal of injectable tylosin in swine.
Sampson GR; Sauter RA; Gregory RP
Mod Vet Pract; 1974 Apr; 55(4):261. PubMed ID: 4824798
[No Abstract] [Full Text] [Related]
3. Evaluation of tylocin-neomycin powder in treatment of bovine pinkeye.
Sampson GR; Gregory RP
Vet Med Small Anim Clin; 1974 Feb; 69(2):166-7. PubMed ID: 4492811
[No Abstract] [Full Text] [Related]
4. [Evaluation of the efficacy and tolerability of miocamycin in the treatment of otorhinololaryngologic infection by sensitive micro-organisms].
Bellioni P; Di Luzio Paparatti U; Salvinelli F; Artuso A
Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):293-8. PubMed ID: 3509888
[No Abstract] [Full Text] [Related]
5. The injection of turkey hatching eggs with tylosin to eliminate Mycoplasma meleagridis infection.
Hofstad MS
Avian Dis; 1974; 18(1):134-8. PubMed ID: 4856000
[No Abstract] [Full Text] [Related]
6. The aminoglycosides.
Tuazon C
Ear Nose Throat J; 1981 May; 60(5):233-8. PubMed ID: 7227273
[No Abstract] [Full Text] [Related]
7. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. I. The appearance of resistance to antibiotics in bacteria].
Midan F; Lengyel Z; Dumitrescu M
Otorinolaringologie; 1968; 13(4):315-24. PubMed ID: 5720732
[No Abstract] [Full Text] [Related]
8. [A medium spectrum antibiotic in the therapy of ORL infections].
López Rubio A; Estrada Velasco A; Ibarra J; Lazos O
Prensa Med Mex; 1975; 40(7-8):256-8. PubMed ID: 768969
[No Abstract] [Full Text] [Related]
9. [Controlled studies of the acivity of Xanthocycline, in aosol and oral administration, in some otorhinolaryngological bacterial diseases].
Lipozencic M; Petric K; Radej I; Trubic I
Minerva Otorinolaringol; 1969; 19(5):285-94. PubMed ID: 5380543
[No Abstract] [Full Text] [Related]
10. [Bacterial contamination in a polyvalent resuscitation department and resistance of the bacteria to antibiotics].
Griffe O; Kienlen J; Serre A; Du Cailar J
Ann Anesthesiol Fr; 1974; 15(3):215-22. PubMed ID: 4466393
[No Abstract] [Full Text] [Related]
11. [Value of tobramycin in pediatrics. Apropos of 40 cases].
Gilly R; Fougerat J
Nouv Presse Med; 1974 Apr; 3(0):72-4. PubMed ID: 4599829
[No Abstract] [Full Text] [Related]
12. [Chlormethylencycline in otorhinolaryngologic diseases. (Clinical trials)].
Di Brino M; Baldiserri L
Atti Accad Fisiocrit Siena Med Fis; 1967; 16(1):329-41. PubMed ID: 5621897
[No Abstract] [Full Text] [Related]
13. [The efficacy of terazolidone in bacterial gastoenteritis].
Fiaccadori F; Pizzaferri A
Prensa Med Mex; 1974; 39(9-10):425-32. PubMed ID: 4457878
[No Abstract] [Full Text] [Related]
14. [Therapeutic results of Kanendomycin in infectious otorhinolaryngological diseases and its effect on the organ of hearing].
Mibe T
Nihon Ishikai Zasshi; 1969 Sep; 62(6):537-42. PubMed ID: 5390379
[No Abstract] [Full Text] [Related]
15. [Antibacterial activity of tobramycin].
Acar JF
Nouv Presse Med; 1974 Apr; 3(0):57-9. PubMed ID: 4600179
[No Abstract] [Full Text] [Related]
16. [Urinary pathogenic bacteria in general practice. Incidence and antibiotic resistance].
Digranes A; Dibb WL; Benonisen E
Tidsskr Nor Laegeforen; 1983 May; 103(14):1183-6. PubMed ID: 6879554
[No Abstract] [Full Text] [Related]
17. Selecting an oral broad-spectrum antibiotic.
Poole MD
Ear Nose Throat J; 1992 Sep; 71(9):444-5. PubMed ID: 1425385
[No Abstract] [Full Text] [Related]
18. [Clinical study of a new macrolide, miocamycin, in 150 patients with otorhinolaryngologic disorders].
Ursino F; Grosjacques M; Panattoni G; Pardini L; Matteucci F
Clin Ter; 1987 Jul; 122(1):13-6. PubMed ID: 2973891
[No Abstract] [Full Text] [Related]
19. [The genetic basis of the variability of germs in otorhinolaryngologic diseases. II. Appearance of resistance to antibiotics due to recombinations].
Lengyel Z; Midan F; Dumitrescu M
Otorinolaringologie; 1968; 13(4):325-36. PubMed ID: 5720733
[No Abstract] [Full Text] [Related]
20. [Advantages of a painless and colorless topical agent in otorhinolaryngology].
Appaix A; Dinand F; Houel B
Mars Med; 1971; 108(1):79-81. PubMed ID: 4323276
[No Abstract] [Full Text] [Related]
[Next] [New Search]
